Counterpoint Research released its consumer wearables forecast, projecting that the global market will generate more than $1 trillion in cumulative revenue between now and 2032. Apple Watch and AirPods are positioned at the center of this growth, with hearables and smartwatches alone accounting for $558 billion of that total.
Hearables will account for the largest slice of cumulative revenue at roughly $360 billion, followed by smartwatches at $304 billion. Smart eyewear comes in third at $168 billion, with health patches at $120 billion, smart rings at $44 billion, and smaller categories including pendants, smart shoes, and fitness bands rounding out the forecast. The dominance of the first two categories leaves little room for competitors to claim meaningful market share by 2032. Apple’s AR smart glasses could factor into that smart eyewear segment as the market matures.
Apple’s wearables business has entered a growth phase after a painful contraction in 2024. The company reported $7.88 billion in revenue for its Wearables, Home and Accessories segment in fiscal Q3 2026, up 6 percent year over year and representing the strongest growth in that category since fiscal Q4 2022.
More Apple’s smartwatch shipments surged 21 percent during the first three months of 2026, reaching a 23 percent share of the global smartwatch market while the category itself grew only 4 percent year over year. This gap reflects Apple’s ability to pull market share through hardware innovation. The company’s complete portfolio refresh in 2025, with the Series 11, Ultra 3, and SE 3 introducing features such as 5G RedCap support, hypertension notification, and satellite connectivity, drove upgrades from existing users and new purchases alike.
Counterpoint estimates that AirPods alone will surpass $100 billion in cumulative revenue in 2026, showing the sustainability of Apple’s hearables dominance. Camera-equipped AirPods are expected to launch in September and could further accelerate that trajectory.
Apple’s competitive advantage in wearables is increasingly tied to on-device artificial intelligence processing. Global shipments of Edge AI-capable smartwatches grew 70 percent year over year in Q1 2026, with Apple accounting for roughly 90 percent of the total.
This concentration reflects Apple Watch’s head start in integrating advanced machine learning directly on the device rather than relying on cloud connectivity. As wearables evolve toward real-time health monitoring and predictive alerts, the ability to process AI workloads locally becomes a critical differentiator that competitors have struggled to match at scale. The upcoming Apple Watch Series 12 and Ultra 4 chip upgrade is expected to push that advantage even further.
The wearables market is shifting away from basic fitness tracking toward preventive health, where the device flags a problem before the user notices. Apple’s health-focused hardware and software strategy is positioned to benefit directly from this transition.
The adoption of clinical-grade health features accelerated dramatically between Q1 2025 and Q1 2026. Blood pressure monitoring jumped from 11 percent to 23 percent of smartwatch shipments, sleep apnea detection rose from 5 percent to 18 percent, and ECG capability expanded from 31 percent to 34 percent. Average smartwatch selling prices increased 6 percent during the period, driven by “the integration of improved sensors and advanced technologies to support health monitoring and AI capabilities.”
Apple’s integration of these sensors with its Health app and medical-grade feature set gives it structural advantages in a market increasingly defined by clinical validation rather than step counts. iOS 27’s deeper Apple Watch integration is one example of how Apple is tightening the bond between its devices and health ecosystem.
Counterpoint’s forecast assumes sustained demand for incremental hardware upgrades within existing wearables categories through 2032. Apple is reportedly exploring screenless fitness bands, smart rings, and smart glasses, placed to participate in emerging wearable categories beyond its current Watch and AirPods franchises.
The $1 trillion forecast is not a given, it assumes health monitoring features continue to drive upgrade cycles, that on-device AI remains a consumer priority, and that Apple and rivals maintain pricing power. But the trend lines point clearly toward a wearables market increasingly defined by clinical utility rather than novelty, and that is precisely the market Apple has spent the last eighteen months building for.
